JMP Securities restated their market perform rating on shares of HealthStream (NASDAQ:HSTM – Free Report) in a report released on Thursday morning,Benzinga reports.
HSTM has been the topic of several other research reports. Canaccord Genuity Group lifted their price target on HealthStream from $28.00 to $29.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Barclays raised their price objective on shares of HealthStream from $32.00 to $34.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Finally, Craig Hallum upgraded shares of HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th. Two analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $31.50.
Read Our Latest Analysis on HealthStream
HealthStream Stock Performance
Institutional Trading of HealthStream
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Barclays PLC increased its holdings in shares of HealthStream by 145.0% in the 3rd quarter. Barclays PLC now owns 58,838 shares of the technology company’s stock worth $1,697,000 after acquiring an additional 34,821 shares during the period. State Street Corp increased its stake in shares of HealthStream by 1.2% in the third quarter. State Street Corp now owns 974,235 shares of the technology company’s stock valued at $28,097,000 after purchasing an additional 11,976 shares during the period. Harbor Capital Advisors Inc. boosted its position in shares of HealthStream by 141.2% during the third quarter. Harbor Capital Advisors Inc. now owns 400,033 shares of the technology company’s stock worth $11,537,000 after buying an additional 234,148 shares during the period. JPMorgan Chase & Co. grew its holdings in HealthStream by 18.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 57,204 shares of the technology company’s stock worth $1,650,000 after buying an additional 9,017 shares in the last quarter. Finally, FMR LLC increased its position in HealthStream by 24.0% in the 3rd quarter. FMR LLC now owns 119,067 shares of the technology company’s stock valued at $3,434,000 after acquiring an additional 23,055 shares during the period. 69.58% of the stock is owned by institutional investors.
HealthStream Company Profile
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Further Reading
- Five stocks we like better than HealthStream
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- What Are Dividends? Buy the Best Dividend Stocks
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.